Level of serum 25(OH) vitamin D among hospitalized COVID-19 patients in Iraq, Diwaniyah city
Keywords:
COVID-19, serum 25(OH), Vitamin DAbstract
Introduction: COVID-19 is an emerging viral infection whose pathogenic mechanisms are not well understood. Interestingly, Vitamin D deficiency and COVID-19 share prevalence patterns for hypertension, diabetes, obesity, advanced age, and male sex. Vitamin D deficiency can contribute to our understanding of COVID-19 health disparities. Patients and methods: a cross sectional study involving 100 adult hospitalized patients with positive PCR for COVID-19 at Diwaniyah teaching Hospital / Shiffaa center, Diwaniyah, Iraq, during a period of 3 months. The serum 25 OH-D level was measured and Vitamin D deficiency, defined as a 25(OH) D level < 20 ng/mL, and insufficiency define as a 25(OH)D level 30-20 ng/mL. History of some other underlying health diseases (diabetes mellitus, hypertension, hypothyroidism and gastro esophageal reflux disease) was taken directly from the patients. The data was analyzed using SPSS version 26 and the study aimed to measure serum vitamin D level among COVID-19 patients. Result: The mean ± SD age was 38.8±13.7 years ranging between 18- 67 years. The mean±SD of 25(OH)D levels was 20.2±16 ng/mL. Vitamin D deficiency was present in 58 patients and vit D insufficiency was found in 25 patients.
Downloads
References
Holick MF. Vitamin D: extraskeletal health. Rheumatic Disease Clinics. 2012;38(1):141-60.
Müller DN, Kleinewietfeld M, Kvakan H. Vitamin D review. Journal of the renin-angiotensin-aldosterone system. 2011;12(2):125-8.
Mazahery H, Von Hurst PR. Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients. 2015;7(7):5111-42.
Laird E, Rhodes J, Kenny RA. Vitamin D and inflammation: potential implications for severity of Covid-19. Ir Med J. 2020;113(5):81.
Kakodkar P, Kaka N, Baig M. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020;12(4).
Kara M, Ekiz T, Ricci V, Kara Ö, Chang K-V, Özçakar L. ‘Scientific Strabismus’ or two related pandemics: coronavirus disease and vitamin D deficiency. British Journal of Nutrition. 2020;124(7):736-41.
Hribar CA, Cobbold PH, Church FC. Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain sciences. 2020;10(5):284.
Rusińska A, Płudowski P, Walczak M, Borszewska-Kornacka MK, Bossowski A, Chlebna-Sokół D, et al. Vitamin D supplementation guidelines for general population and groups at risk of vitamin D deficiency in Poland—recommendations of the polish Society of Pediatric Endocrinology and Diabetes and the expert panel with participation of national specialist consultants and representatives of scientific societies—2018 update. Frontiers in endocrinology. 2018;9:246.
Molloy E, Murphy N. Vitamin D, Covid-19 and children. Ir Med J. 2020;113(4):64.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.
Carlberg C. The physiology of vitamin D—far more than calcium and bone. Frontiers in physiology. 2014;5:335.
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Annals of epidemiology. 2009;19(2):73-8.
Vanherwegen A-S, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinology and Metabolism Clinics. 2017;46(4):1061-94.
Olliver M, Spelmink L, Hiew J, Meyer-Hoffert U, Henriques-Normark B, Bergman P. Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae. The Journal of infectious diseases. 2013;208(9):1474-81.
Greiller C, Martineau A. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015; 7: 4240–70. PUBMED.
Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD, et al. Vitamin D insufficiency is prevalent in severe COVID-19. MedRxiv. 2020.
Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi‐Aliabadi M, Jafarzadeh B, et al. The association between the level of serum 25 (OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID‐19 infection: A case–control study of hospitalized patients in Tehran, Iran. Journal of medical virology. 2021;93(4):2359-64.
Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PloS one. 2020;15(9):e0239252.
Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA network open. 2020;3(9):e2019722-e.
Seal KH, Bertenthal D, Carey E, Grunfeld C, Bikle DD, Lu CM. Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality. Journal of general internal medicine. 2022:1-9.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, et al. Mechanisms in endocrinology: vitamin D and COVID-19. European journal of endocrinology. 2020;183(5):R133-R47.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet. 2020;395(10229):1033-4.
Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S, et al. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clinical Nutrition. 2021;40(4):2469-72.
Gavioli EM, Miyashita H, Hassaneen O, Siau E. An evaluation of serum 25-hydroxy Vitamin D levels in patients with COVID-19 in New York City. Journal of the American Nutrition Association. 2022;41(2):201-6.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
